1. Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)
Number of Hedge Fund Holders: 40
Market Capitalization: $1.62 billion
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) is among the best pharmaceutical stocks.
TheFly reported on May 7 that AMLX reported first-quarter 2026 results for the period ended March 31, 2026, alongside pipeline and clinical updates. R&D expenses rose to $27.6 million from $22.1 million a year earlier, driven mainly by increased spending on avexitide development for post-bariatric hypoglycemia and milestone payments tied to the AMX0318 program. SG&A expenses increased slightly to $16.2 million from $15.7 million due to higher professional and consulting costs. Net loss widened to $41.3 million, or $0.37 per share, compared with $35.9 million, or $0.42 per share, in the prior-year period. The company ended the quarter with $279.8 million in cash, cash equivalents, and short-term investments, supporting operations into 2028.
Moreover, earlier on May 5, Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) announced the initiation of a U.S. Expanded Access Program allowing treatment access to avexitide for up to 250 adults with post-bariatric hypoglycemia. The program provides physicians the ability to request the investigational glucagon-like peptide-1 receptor antagonist for patients with significant unmet medical needs who cannot join ongoing clinical trials and have limited remaining treatment options.
Eligibility includes individuals with PBH following Roux-en-Y gastric bypass surgery, including those who have completed the Phase 3 LUCIDITY trial or previously participated in related studies. The program is designed to expand controlled access to avexitide under defined clinical criteria while broader development continues for the therapy in PBH.
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) is a clinical-stage biopharmaceutical company developing therapies for neurodegenerative and endocrine diseases with high unmet medical needs.
While we acknowledge the potential of AMLX to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than AMLX and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
